article thumbnail

COVID-19: How RNs Can Help Overcome Public Vaccine Hesitancy

Penn Nursing

However, near the end of the document, in Chapter 7, “Achieving Acceptance of COVID-19 Vaccine,” the authors acknowledge that “distrust in the government, in the medical research community, and in pharmaceutical companies” is a key factor in “COVID-19 vaccine hesitancy.”

article thumbnail

Jill Fallows Macaluso Esq., RN

Penn Nursing

RN How one Penn Nursing grad is upholding ethics in the pharmaceutical industry. Today they are one of the leading pharmaceutical companies in the world, known for medicines treating the chronic diseases of diabetes and obesity, and for supplying fifty percent of the world’s insulin. “I Menu Button Jill Fallows Macaluso Esq.,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What to expect from tonight’s federal budget: Health and cost of living relief

Nursing Review

As per recent announcements, it is expected that we will see money committed to the reduction of most Pharmaceutical Benefits Scheme (PBS) medicines. trillion figure forecast in the pre-election financial outlook prior to the 2022 election.

article thumbnail

Australia’s medicine supply shortages explained

Nursing Review

As of March, the Therapeutic Goods Administration (TGA) has more than 400 medications listed as experiencing shortages, whereas in March 2022 that number was at 263. Pharmaceutical shortages in Australia are complex, as each medication has numerous ingredients with their own supply and demand pressures.

article thumbnail

Australia has a breast cancer problem

Nursing Review

The Global Patterns and Trends in Breast Cancer Incidence and Mortality report uses 2022 data from 185 countries to project the global breast cancer impact by 2050. Of the estimated 10,732 working-age Australian women diagnosed withbreastcancer in 2022, they will collectively lose a projected AU$1.4

article thumbnail

Nursing Education: Pipeline to the Future

Minority Nurse

in 2022, the first decrease in 20 years. In 2022, 66,261 candidates were rejected, and in 2021 applications by 76,140 candidates were turned down. from 2021 to 2022. Master ’ s programs have seen a 9.4% decrease since 2021. Nursing PhD program enrollment shrank 4.1% DNP program enrollment is at a virtual standstill.

article thumbnail

Meet a Champion of Nursing Diversity: Rekha Daniel-Kimani

Minority Nurse

Daniel-Kimani joined BAYADA in 2017 as director of benefits and compensation, and then in January 2022, Daniel-Kimani became head of total rewards, DEI, and HR strategy to ensure employees are effectively compensated and recognized and to help both current and prospective employees find their unique connection to BAYADA’s mission and values.